PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Experimental Diabetes and Obesity Drug Shows Positive Results

A new experimental drug from Novo Nordisk has demonstrated significant weight loss and lower blood sugar levels in trials, including phase 2 trials conducted in China, showing positive results for diabetes and obesity treatment, as further confirmed by recent reports.

25 Mar, 07:19 — 25 Mar, 07:19
PostShare

Sources

Showing 1 of 4 sources
wsjHigh11d ago

Novo Nordisk Says Experimental Diabetes and Obesity Drug Shows Positive Results - WSJ

Novo Nordisk Says Experimental Diabetes and Obesity Drug Shows Positive Results  WSJ

Read full article →

Coverage Timeline

First report: berlingske · 25 Mar, 06:45Full coverage: 4 · 51mWindow: 51m
Left-leaningCenterRight-leaning
berlingske25 Mar, 06:45First to report

Nyt Novo-middel viser reduktion i vægt og blodsukker i Kina

wsj25 Mar, 07:19

Novo Nordisk Says Experimental Diabetes and Obesity Drug Shows Positive Results - WSJ

politiken25 Mar, 07:25

Nyt Novo-middel viser reduktion i vægt og blodsukker i Kina

dr-dk25 Mar, 07:37Latest update

Nyt Novo-middel viser fald i vægt og blodsukker i fase 2-studie i Kina

Related Stories

Panglao Island Sees Steady Tourist Arrivals During Holy Week

just now

Isabela Greenhouse Project Boosts Farmers' Income Amid Oil Crisis

just now

Great Britain will abandon the ban on foie gras and fur to facilitate a trade agreement with the EU

17m ago

Turkey and Armenia - just waiting to open border crossings

19m ago